These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15518768)

  • 1. Therapeutic implication of quantitative pp65 antigen assay in living renal transplant in a high seroendemic population.
    Minz RW; Minz M; Kashyap R; Heer M; Udgiri N; Joshi K; Sakhuja VK
    Transplant Proc; 2004 Sep; 36(7):2120-1. PubMed ID: 15518768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of antigenemia assay in the early diagnosis and treatment of CMV infection in renal transplant patients.
    Chiaramonte S; Pellizzer G; Rassu M; Dissegna D; Bragantiini L; Zuccarotto D; La Greca G
    Clin Nephrol; 2000 Apr; 53(4):suppl 10-2. PubMed ID: 10809428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential cytomegalovirus antigenemia monitoring in kidney transplant patients treated with antilymphocyte antibodies.
    Ozaki KS; Pestana JO; Granato CF; Pacheco-Silva A; Camargo LF
    Transpl Infect Dis; 2004 Jun; 6(2):63-8. PubMed ID: 15522106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
    Schvoerer E; Henriot S; Zachary P; Freitag R; Fuchs A; Fritsch S; Risch S; Meyer N; Caillard S; Lioure B; Stoll-Keller F
    J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
    Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
    Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
    Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
    J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
    Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
    Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
    Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
    J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
    Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
    J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients.
    Bordils A; Plumed JS; Ramos D; Beneyto I; Mascarós V; Molina JM; Cordoba J; García J; Crúz JM
    Transplant Proc; 2005 Nov; 37(9):3756-9. PubMed ID: 16386529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenemia for cytomegalovirus in renal transplantation: choosing a cutoff for the diagnosis criteria in cytomegalovirus disease.
    Schröeder R; Michelon T; Fagundes I; Bortolotto A; Lammerhirt E; Oliveira J; Santos A; Bittar A; Keitel E; Garcia V; Neumann J; Saitovitch D
    Transplant Proc; 2005; 37(6):2781-3. PubMed ID: 16182809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid immunodiagnosis of active cytomegalovirus infection by pp65 antigenemia assay.
    Jahan M; Tabassum S; Islam MN
    Bangladesh Med Res Counc Bull; 2006 Apr; 32(1):22-8. PubMed ID: 17665830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between RFLP-PCR and antigenemia for pp65 antigen for diagnosis of cytomegalovirus disease after kidney transplantation.
    Schröeder R; Michelon T; Fagundes I; Bortolotto A; Petry M; Lammerhirt E; Santos L; Cantarelli V; Keitel E; Garcia V; Neumann J
    Transplant Proc; 2004 May; 36(4):891-3. PubMed ID: 15194306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between pp65 antigenemia, RT-PCR and viruria for cytomegalovirus detection in kidney transplant recipients.
    Solà R; Rabella N; Guirado LL; Díaz JM; Facundo C; García R
    Transplant Proc; 2005 Nov; 37(9):3768-9. PubMed ID: 16386533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
    Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
    J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and monitoring of cytomegalovirus infection in renal transplant patients by quantitative real-time PCR.
    Madi N; Al-Nakib W; Mustafa AS; Saeed T; Pacsa A; Nampoory MR
    Med Princ Pract; 2007; 16(4):268-73. PubMed ID: 17541291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients.
    Pellegrin I; Garrigue I; Ekouevi D; Couzi L; Merville P; Merel P; Chene G; Schrive MH; Trimoulet P; Lafon ME; Fleury H
    J Infect Dis; 2000 Jul; 182(1):36-42. PubMed ID: 10882579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is combined pretransplantation seropositivity of kidney transplant recipients for cytomegalovirus antigens (pp150 and pp28) a predictor for protection against infection?
    Essa S; Pacsa A; Said T; Nampoory MR; Raghupathy R; Johny KV; Al-Nakib W; Al-Mosawy M
    Med Princ Pract; 2008; 17(1):66-70. PubMed ID: 18059104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of human Cytomegalovirus infection by antigenemia and viremia in the first 100 days following renal transplantation and relation to antiviral strategies.
    Terlizzi ME; Costa C; Astegiano S; Sidoti F; Vendrame R; Segoloni GP; Bergallo M; Cavallo R
    Minerva Med; 2008 Jun; 99(3):231-9. PubMed ID: 18497721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.